Bile acids for probucol formulations applications in drug induced ototoxicity
Within this thesis, probucol’s otoprotective application is assessed in vitro on House Ear Institute-Organ of Corti 1 (HEI-OC1) using three different formulation methods; 1) spray dried, 2) chitosan films or 3) supramolecular aggregates. To improve pre-formulation stability and drug loading, probuco...
| Main Author: | Ionescu, Corina Mihaela |
|---|---|
| Format: | Thesis |
| Published: |
Curtin University
2024
|
| Online Access: | http://hdl.handle.net/20.500.11937/96021 |
Similar Items
Application of bile acids in drug formulation and delivery
by: Stojancevic, M., et al.
Published: (2014)
by: Stojancevic, M., et al.
Published: (2014)
An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer
by: Mooranian, Armin, et al.
Published: (2014)
by: Mooranian, Armin, et al.
Published: (2014)
Novel artificial cell microencapsulation of probucol and bile acids in diabetes mellitus
by: Mooranian, Armin
Published: (2018)
by: Mooranian, Armin
Published: (2018)
Bile acid-based micro/nano capsules for the targeted oral delivery of probucol
by: Wagle, Susbin Raj
Published: (2020)
by: Wagle, Susbin Raj
Published: (2020)
Eudragit®-based microcapsules of probucol with a gut-bacterial processed secondary bile acid
by: Mooranian, A., et al.
Published: (2018)
by: Mooranian, A., et al.
Published: (2018)
The effect of a tertiary bile acid, taurocholic acid, on the morphology and physical characteristics of microencapsulated probucol: potential applications in diabetes: a characterization study
by: Mooranian, A., et al.
Published: (2015)
by: Mooranian, A., et al.
Published: (2015)
Swelling, mechanical strength, and release properties of probucol microcapsules with and without a bile acid, and their potential oral delivery in diabetes
by: Negrulj, R., et al.
Published: (2015)
by: Negrulj, R., et al.
Published: (2015)
The applications of microencapsulated formulation of gliclazide and bile acids in Type-1 diabetes mellitus
by: Mathavan, Sangeetha
Published: (2017)
by: Mathavan, Sangeetha
Published: (2017)
An advanced microencapsulated system: a platform for optimized oral delivery of antidiabetic drug-bile acid formulations
by: Mooranian, A., et al.
Published: (2015)
by: Mooranian, A., et al.
Published: (2015)
Exposure to noise and ototoxic chemicals in the Australian workforce
by: Lewkowski, K., et al.
Published: (2019)
by: Lewkowski, K., et al.
Published: (2019)
A study of
mitochondrial A1555G mutation in
aminogl ycoside induced ototoxicity
by: Eshamsol Kamar, Omar
Published: (2008)
by: Eshamsol Kamar, Omar
Published: (2008)
Pharmacological effects of nanoencapsulation of human-based dosing of probucol on ratio of secondary to primary bile acids in gut, during induction and progression of type 1 diabetes
by: Mooranian, Armin, et al.
Published: (2018)
by: Mooranian, Armin, et al.
Published: (2018)
Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics
by: Mikov, M., et al.
Published: (2017)
by: Mikov, M., et al.
Published: (2017)
Advanced bile acid-based multi-compartmental microencapsulated pancreatic ß-cells integrating a polyelectrolyte-bile acid formulation, for diabetes treatment.
by: Mooranian, A., et al.
Published: (2014)
by: Mooranian, A., et al.
Published: (2014)
Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles
by: Pavlovic, N., et al.
Published: (2018)
by: Pavlovic, N., et al.
Published: (2018)
Novel chenodeoxycholic acid-sodium alginate matrix in the microencapsulation of the potential antidiabetic drug, probucol. An in vitro study
by: Mooranian, A., et al.
Published: (2015)
by: Mooranian, A., et al.
Published: (2015)
Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol
by: Mooranian, Armin, et al.
Published: (2014)
by: Mooranian, Armin, et al.
Published: (2014)
The application of novel nano-capsules containing probucol-lithocholic acid to counteract oxidative stress
by: Wagle, Susbin Raj
Published: (2025)
by: Wagle, Susbin Raj
Published: (2025)
Lipid components of bile increase the protective effect of conjugated bile salts against antifungal drugs
by: Hsieh, Shih-Hung, et al.
Published: (2017)
by: Hsieh, Shih-Hung, et al.
Published: (2017)
Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome
by: Danic, M., et al.
Published: (2018)
by: Danic, M., et al.
Published: (2018)
The role of the bile acid chenodeoxycholic acid in the targeted oral delivery of the anti-diabetic drug gliclazide, and its applications in type 1 diabetes
by: Mathavan, S., et al.
Published: (2015)
by: Mathavan, S., et al.
Published: (2015)
Psychometric validation of questionnaire towards awareness of ototoxicity risk due to solvent exposure
by: Ainul Naqueah, Zainal Abidin, et al.
Published: (2022)
by: Ainul Naqueah, Zainal Abidin, et al.
Published: (2022)
Probucol Suppresses Enterocytic Accumulation of Amyloid-β Induced by Saturated Fat and Cholesterol Feeding
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2011)
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2011)
An in vivo pharmacological study: Variation in tissue-accumulation for the drug probucol as the result of targeted microtechnology and matrix-acrylic acid optimization and stabilization techniques
by: Mooranian, Armin, et al.
Published: (2019)
by: Mooranian, Armin, et al.
Published: (2019)
Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: A Characterization Study
by: Mooranian, Armin, et al.
Published: (2014)
by: Mooranian, Armin, et al.
Published: (2014)
Bile Acids Repress Hypoxia-Inducible Factor 1 Signaling and Modulate the Airway Immune Response
by: Legendre, C., et al.
Published: (2014)
by: Legendre, C., et al.
Published: (2014)
Extraction and quantitative determination of bile acids in feces
by: Shafaei, A., et al.
Published: (2021)
by: Shafaei, A., et al.
Published: (2021)
Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment
by: Mooranian, Armin, et al.
Published: (2015)
by: Mooranian, Armin, et al.
Published: (2015)
Effects of the cannabinoid CB1 agonist ACEA on salicylate ototoxicity, hyperacusis and tinnitus in guinea pigs
by: Berger, Joel I., et al.
Published: (2017)
by: Berger, Joel I., et al.
Published: (2017)
Dissecting the regulation of bile-induced biofilm formation in Staphylococcus aureus.
by: Ulluwishewa, D., et al.
Published: (2016)
by: Ulluwishewa, D., et al.
Published: (2016)
Rethinking the bile acid/gut microbiome axis in cancer
by: Phelan, J., et al.
Published: (2017)
by: Phelan, J., et al.
Published: (2017)
Bile acids and probiotics could help treating diabetes
by: Calasan, J., et al.
Published: (2012)
by: Calasan, J., et al.
Published: (2012)
The roles of bile acids and applications of microencapsulation technology in treating Type 1 diabetes mellitus
by: Woodhams, L., et al.
Published: (2017)
by: Woodhams, L., et al.
Published: (2017)
Prevention and Management Intervention (PMI) of occupational ototoxic exposure in industrial perspective globally : A systematic review
by: Ainul Naqueah, Zainal Abidin, et al.
Published: (2022)
by: Ainul Naqueah, Zainal Abidin, et al.
Published: (2022)
Probucol prevents blood-brain barrier dysfunction in wild-type mice induced by saturated fat or cholesterol feeding
by: Takechi, Ryu, et al.
Published: (2013)
by: Takechi, Ryu, et al.
Published: (2013)
Bile acid-based bio micro/nanotechnologies;
biocompatibility studies
by: Kovacevic, Božica
Published: (2024)
by: Kovacevic, Božica
Published: (2024)
Investigating the bile acid mediated control of Clostridioides difficile infection
by: von Emloh, Louise
Published: (2024)
by: von Emloh, Louise
Published: (2024)
The antimicrobial and bile acid mediated control of
Clostridium difficile infection
by: Dempster, Andrew William
Published: (2018)
by: Dempster, Andrew William
Published: (2018)
Strain differences in deconjugation of bile acids in Bifidobacterium pseudocatenulatum isolates
by: Sabet, Maryam Rezaei, et al.
Published: (2004)
by: Sabet, Maryam Rezaei, et al.
Published: (2004)
Acid and bile tolerance of Lactobacillus isolated from chicken intestine
by: Jin, Li Zhi, et al.
Published: (1998)
by: Jin, Li Zhi, et al.
Published: (1998)
Similar Items
-
Application of bile acids in drug formulation and delivery
by: Stojancevic, M., et al.
Published: (2014) -
An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer
by: Mooranian, Armin, et al.
Published: (2014) -
Novel artificial cell microencapsulation of probucol and bile acids in diabetes mellitus
by: Mooranian, Armin
Published: (2018) -
Bile acid-based micro/nano capsules for the targeted oral delivery of probucol
by: Wagle, Susbin Raj
Published: (2020) -
Eudragit®-based microcapsules of probucol with a gut-bacterial processed secondary bile acid
by: Mooranian, A., et al.
Published: (2018)